Skip to main content

AOA Category 1-B credits and AMA PRA Category 1 CME

Courses to fit your schedule

Busy healthcare professionals enjoy the ease of our enduring on-demand, AOA Category 1-B and AMA PRA Category 1 courses. Participants must complete the entire activity and complete all required forms to qualify for credit and receive a certificate.

Explore our CME programs below, then visit the Rowan University Online Marketplace to register today!

Register Now

End-of-Life / Palliative Care

2 AOA Category 1-B credits and/or 2 AMA PRA Category 1 credits

This CME satisfies the State of NJ licensing renewal requirements for End-of-Life/Palliative Care Training. The method of delivery for the End-of-Life/Palliative Care Continuing Medical Education activity will be an enduring on-demand two-hour program. The training session is provided visually by PowerPoint presentation and in audio by hearing the speaker’s voice.

Register Now!

$49 - 2 AOA Category 1-B credits / 2 AMA PRA Category 1 credits

Topics Presented

Selected Topics in Hospice and Palliative Care
Leonard Powell, DO
Assistant Professor, Geriatrics and Gerontology, Rowan-Virtua SOM

Goals of Care and Advance Care Planning
Paul Bryman, DO
Assistant Professor, Geriatrics and Gerontology, Rowan-Virtua SOM

General Learning Objectives

Participants will:

    1. Manage End-of-Life symptoms
    2. Identify End-Stage chronic disease states
    3. Articulate the philosophy of hospice
    4. Illustrate delivery of hospice care
    5. Employ the purpose and function of a POLST form
    1. Construct a goals of care conversation in patients with advance disease and life limiting illness
    2. Implement best practices when delivering serious news to patients
    3. Employ the SPIKES and REMAP techniques in listening and responding to patients during goals of care conversations
    4. Formulate a treatment plan that matches the patient's goals and values​

Method of Participation

For successful completion of this activity, awarding of credits and to receive a certificate, individuals are required to participate in the entire activity and complete an attestation form, outcome survey and an evaluation form. Certificates will be e-mailed out within two weeks. 

Accreditation and Designation Statements

Rowan-Virtua SOM is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. 

Rowan-Virtua SOM designates this enduring activity for a maximum of 2 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

Rowan-Virtua SOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Rowan-Virtua SOM designates this enduring activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.

Release Date: January 1, 2025
Expiration Date: December 31, 2027

Cancellation/Refund Policy: Your registration fee, less a $25 administrative fee, will be refunded if requested in writing before beginning the course. Requests must be made within one week from registration.


Tobacco/Nicotine Dependence Screening and Treatment

2 AOA Category 1-B / 2 AMA PRA Category 1 credits

This is an enduring recorded course series that will use a standardized, evidence-based tobacco use disorder prevention, and treatment curriculum to train and inform New Jersey health care licensees with prescribing authority, in compliance with federal and state statutory and regulatory guidelines. This enduring recorded course is designed to inform New Jersey health care professionals on a comprehensive review of tobacco use disorder.

 

Register Now!

Free - 2 AOA Category 1-B / 2 AMA PRA Category 1 credits

Learning Objectives:

  • Develop an understanding of the history of tobacco use and its societal impact
  • Identify brain regions responsible for the neurobiology of tobacco use
  • Recognize risk factors for tobacco use
  • Illustrate the significant health consequences of tobacco use
  • Diagnose tobacco use disorder using DSM-5 criteria
  • Assess level of nicotine dependence
  • Plan effective strategies for cessation of tobacco

Method of Participation

For successful completion of this activity and awarding of credits, individuals are required to participate in the entire activity and complete an attestation form, outcome, and evaluation after the course. 

Accreditation

Rowan-Virtua SOM is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

Rowan-Virtua SOM designates this enduring activity for a maximum of 2 AOA Category 1-B credit and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

Rowan-Virtua SOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Rowan-Virtua SOM designates this enduring activity for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should claim credit commensurate with the extent of their participation in the activity.

Release Date: May 23, 2023
Expiration Date: May 24, 2026


Cannabinoids

2 AOA Category 1-B / 2 AMA PRA Category 1 credits

This is a set of three recorded videos, totaling 2 hours/2 credits. This enduring course will use a standarized, evidence-based, and treatment curriculum to train and inform physicians. This enduring recorded course is designed to inform health care professionals on a comprehensive overview of Cannabinoids.

Register Now!

Free - 2 AOA Category 1-B / 2 AMA PRA Category 1 credits

Learning Objectives:

  • Describe the neurobiology of addiction
  • Discuss the pharmacology of Cannabinoids and differentiate between Cannabinoid receptors
  • Examine epidemiologic trends
  • Discuss the interplay between cannabis use and mental health
  • Discuss pharmacologic and psychosocial treatments
  • Analyze the interplay between the legal and recreational cannabis landscape from a public health perspective
  • Reconcile myths and misconceptions of cannabinoids

Method of Participation

For successful completion of this activity and awarding of credits, individuals are required to participate in the entire activity and complete an attestation form, outcome, and evaluation after the course. 

Accreditation

Rowan-Virtua SOM is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

Rowan-Virtua SOM designates this enduring activity for a maximum of 2 AOA Category 1-B credit and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

Rowan-Virtua SOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Rowan-Virtua SOM designates this enduring activity for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should claim credit commensurate with the extent of their participation in the activity.

Release Date: January 19, 2024
Expiration Date: January 18, 2027

 


Overview of Hospital-based Addiction Care

8.5 AMA PRA Category 1 credits

This is an enduring webinar that will use a standardized, evidence-based substance use disorder (SUD) prevention, treatment, harm reduction, and recovery curriculum to train and inform health care licensees with prescribing authority, in compliance with federal and state statutory and regulatory guidelines. This enduring course is designed to inform New Jersey health care professionals on a comprehensive overview of hospital-based addiction care in both emergency medicine (EM) and inpatient care settings, from management of the most common SUDs to managing patient-directed discharge to harm reduction strategies.

Register Now!

Free - Available Credit:  8.5 AMA PRA Category 1 credits

Learning Objectives:

  • Discuss the neurobiology of addiction, addiction cycle framework (binge/intoxication, withdrawal, and preoccupation/anticipation), and neuroadaptations in the domains of increased incentive salience, decreased brain reward and increased stress, and compromised executive function. 

  • Identify the historical origins of the overdose crisis and influence of policy on its flaws and progressions, and discuss trends and statistics pertaining to medication for addiction treatment (MAT) and lack of access and barriers to utilization. 

  • Recommend reasoning for screening, brief intervention, and referral for treatment (SBIRT) of patients with substance use disorder (SUD) in emergency medicine (EM) and inpatient care settings, and compare various screening methodologies for predicting aberrant substance-related behavior among patients receiving opioids for chronic pain management, and those using illicit fentanyl, heroin, and other substances.

  • Recognize chronic pain management strategies to minimize or avoid the use of opioids for pain management with a special focus on alternative pain therapies including Alternatives to Opiates (ALTO®) and adjunctive treatments to opioids for acute and chronic pain including osteopathic manipulative therapy (OMT). 

  • Distinguish differences between the three Food and Drug Administration (FDA)-approved forms of MAT for opioid use disorder (OUD), other forms of evidence-based treatment for other SUDs, and treatment decisions in EM and inpatient care settings guided by the effectiveness of modalities across the continuum of OUD and other SUD severity. 

  • Implement integration of MAT into EM and inpatient care setting clinical workflows, and articulate the influence of MAT guidelines and policies. 

  • Integrate substance withdrawal management and stabilization in emergency medicine (EM) and inpatient care settings with focus on special populations including people who inject drugs (PWID), patients with co-occurring disorders (COD), pregnant people, adolescents and young adults (AYA), and older adults. 

  • Demonstrate reasoning for increased patient access to psychiatric providers and behavioral health clinicians for COD, and primary care providers (PCP) and infectious disease (ID) specialists for human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV) testing. 

  • Identify the significance of harm reduction strategies and policies as a social and health care intervention for people who use drugs (PWUD) including people who inject drugs (PWID), with a special focus on lifesaving risk mitigation strategies including naloxone, fentanyl test strips (FTS), syringe services programs (SSP), and safer drug consumption services (SCS). 

  • Develop best practices for teaching evidence-based and comprehensive addiction medicine curricula to medical students, residents, and fellows.

Method of Participation

For successful completion of this activity and awarding of credits, individuals are required to participate in the entire activity and complete an attestation form, outcome, and evaluation after the course. 

Accreditation

Rowan-Virtua SOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Rowan-Virtua SOM designates this enduring activity for a maximum of 8.5 AMA PRA Category 1 Credit™. Physicians should claim credit commensurate with the extent of their participation in the activity.

Release Date: February 1, 2024
Expiration Date: January 30, 2027